Institution Directory

Clinical trials at Johns Hopkins

Sites in Baltimore, MD

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1427

Shown on this page

Current sort

Live official records

Conditions: Prostate Cancer
Interventions: Standard of Care IMRT (Photon), Standard of Care Proton Therapy, Proton Arm 1: Standard Proton Therapy, Proton Arm 2: Hypofractionated Proton Therapy; Radiation
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 85 Years · Male only
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 53
States / cities: Birmingham, Alabama • La Jolla, California • Loma Linda, California + 44 more

Conditions: Malignant Peripheral Nerve Sheath Tumors
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 1,050 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2053
U.S. locations: 9
States / cities: Tampa, Florida • Baltimore, Maryland • Bethesda, Maryland + 6 more

Conditions: Epilepsy
Interventions: Music Stimuli; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 4 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer, Adenocarcinoma of the Breast
Interventions: PBI with sequential chemotherapy, PBI with concurrent chemotherapy; Other
Lead sponsor: Richard Zellars; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 10
States / cities: Washington D.C., District of Columbia • Fort Wayne, Indiana • Indianapolis, Indiana + 6 more

Conditions: Amyotrophic Lateral Sclerosis
Interventions: MN-166, placebo; Drug
Lead sponsor: MediciNova; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 10
States / cities: Orange, California • Jacksonville, Florida • Augusta, Georgia + 7 more

Conditions: Burn, Chronic Pain Following Thermal Burn Injury, Non-Pharmacological Interventions, Virtual Reality, Sleep Disturbance, Anxiety, Depressive Symptoms, Fatigue Symptom, Pruritus, Burn Injury, Progressive Muscle Relaxation
Interventions: Virtual Reality-Enhanced Progressive Muscle Relaxation, Standard Progressive Muscle Relaxation; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer
Interventions: carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat, placebo; Drug · Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Female only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2027
U.S. locations: 5
States / cities: Birmingham, Alabama • Indianapolis, Indiana • Annapolis, Maryland + 2 more

Conditions: Kidney Neoplasm
Interventions: Not listed
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years to 100 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Drug Overdose
Interventions: Network overdose prevention, Standard of care health education; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Multiple Myeloma
Interventions: Rimiducid may be administered as indicated; Drug
Lead sponsor: Poseida Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2032
U.S. locations: 13
States / cities: Davis, California • San Diego, California • San Francisco, California + 8 more

Conditions: Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma, Oligodendroglioma, Anaplastic Oligodendroglioma of Brain (Diagnosis), Mixed Oligo-Astrocytoma, Ependymoma, Ganglioglioma, Pylocytic/Pylomyxoid Astrocytoma, Brain Tumor, Glioma, Brain Cancer, Glioblastoma, Glioblastoma Multiforme
Interventions: rQNestin, Cyclophosphamide, Stereotactic biopsy; Drug · Procedure
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 5
States / cities: Baltimore, Maryland • Boston, Massachusetts • New York, New York + 1 more

Conditions: Economic Hardship, Condomless Sex, Utilization, Health Care
Interventions: Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring., Job announcements; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 24 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

About this Johns Hopkins institution page

What this page lists: ClinicalTrials.gov records that list Johns Hopkins in Baltimore, MD as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Johns Hopkins

Filter and sort this campus

Live official records

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Effects of Recorded Music on Clinical and EEG Seizure Activity

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

VR-PMR for Post-Burn Symptoms

Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry

Social Network Overdose Prevention and Education Intervention

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)

About this Johns Hopkins institution page